Safety Study of IHL-305 (Irinotecan Liposome Injection) to Treat Advanced Solid Tumors
Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether IHL-305 (irinotecan liposome injection) is
safe and effective in the treatment of advanced solid tumors.